Non-profit organisation MS Society SA & NT, which supports almost 3,000 clients living with multiple sclerosis, has gone into ...

Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has extended by three months the target action date of its review of the new drug application (NDA) of tolebrutinib, ...

Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosis Paris, September 22, 2025. The US Food and Drug Administration (FDA) has extended by three ...

Privosegtor ACUITY Trial showed Improved LCVA and preservation of Ganglion Cells in Acute Optic Neuritis. Results from a Multicenter Randomized Placebo-Controlled Double-Masked Trial Oculis Holding AG ...

Cobenfy is the first approved drug in about 50 years to treat schizophrenia with a novel approach. Karuna Therapeutics and ...

A new surgically implanted device the size of a lima bean can help control rheumatoid arthritis that isn't responding to ...

An AI tool that simplifies complex text, a smart bracelet that turns public announcements into vibrations - UAE university students have come u ...

The Department for Work and Pensions ( DWP) has revealed that nearly 1.7 million older people in the UK were claiming ...

France's Sanofi said its Dupixent drug jointly developed with Regeneron advanced toward a new indication for chronic hives in the European Union, while the U.S. Food and Drug Administration extended ...

There are only days left to enter one of the most thrilling giveaways of the year: a 2026 Chevrolet Corvette ZR1 Coupe with ...

A woman goes to the doctor voicing concerns about her symptoms, only to have those symptoms minimized, overlooked or ...

For our methodology, we first screened biotech stocks trading below $5 per share and showing positive year-to-date (YTD) ...